Boyko Alexey, Melnikov Mikhail
Department of Neurology, Neurosurgery and Medical Genetic, Prirogov Russian National Research Medical University, 1 Ostrovityanova st., Moscow 117997, Russia.
Department of Neuroimmunology, Federal Center of Brain and Neurotechnology, Federal Medical-Biological Agency of Russia, 1-10 Ostrovityanova st., Moscow 117997, Russia.
Brain Sci. 2020 May 18;10(5):305. doi: 10.3390/brainsci10050305.
In the Russian Federation, multiple sclerosis prevalence rates vary from 10 to 80 cases per 100,000, depending on region and the nationality of the population. The main characteristics of multiple sclerosis epidemiology in the XX century in this big territory are: (1) steady increase in multiple sclerosis prevalence and incidence rates, maybe because of better diagnosis and treatment, but also changes in environmental/epigenetic risk profile and/or lifestyle factors; (2) increase of the female to male ratio, increase in multiple sclerosis incidence mainly in females; (3) appearance and increasing frequency of multiple sclerosis in ethnic groups, previously free of multiple sclerosis (Northern Tribes, Yakuts and others). The latest data show that in European Russia, the multiple sclerosis prevalence varies from 30 to 80 cases, in Siberia-from 20 to 70 cases, with steady increases, especially in women.
在俄罗斯联邦,多发性硬化症的患病率为每10万人中有10至80例,具体取决于地区和人口的民族。在这个幅员辽阔的地区,20世纪多发性硬化症流行病学的主要特征是:(1)多发性硬化症的患病率和发病率稳步上升,这可能是由于诊断和治疗水平提高,但也可能是环境/表观遗传风险状况和/或生活方式因素发生了变化;(2)女性与男性的比例增加,多发性硬化症发病率的上升主要发生在女性中;(3)以前没有多发性硬化症的族群(北方部落、雅库特人等)出现了多发性硬化症且发病率不断上升。最新数据显示,在俄罗斯欧洲部分,多发性硬化症患病率为30至80例,在西伯利亚为20至70例,且呈稳步上升趋势,尤其是在女性中。